Novel oncolytic viral therapies in patients with thoracic malignancies.

about

Immunotherapy for malignant pleural mesothelioma: current status and future directions.Targeting eukaryotic protein translation in mesothelioma

P2860

Q33890551-82961FAA-B983-44AD-B877-9FAF292781C2 Q39438189-123B9674-C2B0-4AD2-B2DA-ABF018EA50DF

P2860

Novel oncolytic viral therapies in patients with thoracic malignancies.

Item

http://www.wikidata.org/entity/Q39067827

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Novel oncolytic viral therapies in patients with thoracic malignancies.

@en

Novel oncolytic viral therapies in patients with thoracic malignancies.

@nl

type

Item

label

Novel oncolytic viral therapies in patients with thoracic malignancies.

@en

Novel oncolytic viral therapies in patients with thoracic malignancies.

@nl

prefLabel

Novel oncolytic viral therapies in patients with thoracic malignancies.

@en

Novel oncolytic viral therapies in patients with thoracic malignancies.

@nl

P1476

Novel oncolytic viral therapies in patients with thoracic malignancies.

@en

P2093

Robert A Kratzke

http://www.w3.org/2001/XMLSchema#string

Zeeshan Ahmad

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like receptor signalling

Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy

Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses

Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide

A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire

Structure of Seneca Valley Virus-001: An Oncolytic Picornavirus Representing a New Genus

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster

Cancer statistics, 2007

Cancer statistics, 2009

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OV.S116012

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28053943

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

5189707

http://www.w3.org/2001/XMLSchema#string

Novel oncolytic viral therapies in patients with thoracic malignancies.

about

P2860

P2860

Novel oncolytic viral therapies in patients with thoracic malignancies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932